DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Oraqix (Lidocaine / Prilocaine Periodontal) - Indications and Dosage

 



INDICATIONS AND USAGE

Oraqix® is indicated for adults who require localized anesthesia in periodontal pockets during scaling and/or root planing.

DOSAGE AND ADMINISTRATION

Apply Oraqix® on the gingival margin around the selected teeth using the blunt-tipped applicator included in the package. Wait 30 seconds, then fill the periodontal pockets with Oraqix® using the blunt-tipped applicator until the gel becomes visible at the gingival margin. Wait another 30 seconds before starting treatment. A longer waiting time does not enhance the anesthesia. Anesthetic effect, as assessed by probing of pocket depths, has a duration of approximately 20 minutes (individual overall range 14 – 31 minutes). If the anesthesia starts to wear off, Oraqix® may be re-applied if needed. The maximum recommended dose of Oraqix® at one treatment session is 5 cartridges, i.e., 8.5g gel. Application of Oraqix® into periodontal pockets without prior application to the gingival margin was tested in one open-label study. This method of application appears to be safe; however, its efficacy has not been tested.

Typically, 1 cartridge (1.7g) or less of Oraqix® will be sufficient for one quadrant of the dentition.

When administered, Oraqix® should be a liquid. If it has formed a gel, it should be placed in a refrigerator (do not freeze) until it becomes a liquid again. When in the liquid state, the air bubble visible in the cartridge will move if the cartridge is tilted.

DO NOT INJECT
Oraqix® should not be used with standard dental anesthetic syringes. Only use this product with the Oraqix® Dispenser, which is available from DENTSPLY Pharmaceutical.

HOW SUPPLIED

Oraqix® (lidocaine and prilocaine periodontal gel), 2.5%/2.5%, is supplied in dental cartridges that provide 1.7g gel. Individually blister-packaged cartridges of Oraqix® are distributed in a carton of 20 (NDC 66312-110-20). Each individual blister package also contains a sterile blunt-tipped applicator. Each blunt-tipped applicator is for single use only.

Store at 25°C (77°F); excursions permitted to 15°-30°C (59°-86°F) [See USP Controlled Room Temperature.]

At temperatures below +5°C Oraqix® may become opaque. This opacity will disappear when the cartridge is warmed to room temperature.

DO NOT FREEZE. Some components of Oraqix® may precipitate if cartridges are frozen. Cartridges should not be used if they contain a precipitate.

Do not use dental cartridge warmers with Oraqix®. The heat will cause the product to gel.

Manufactured for:
DENTSPLY Pharmaceutical
570 West College Avenue
York, PA 17404
By:
Recip AB
Karlskoga
Sweden

Rev. 10/04

68 018 37.80

Page last updated: 2006-06-08

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009